School of Pharmacy, Guangdong Pharmaceutical University, Guangzhou, Guangdong 510006, PR China.
Department of Clinical Laboratory Medicine, Shanghai Tenth People's Hospital of Tongji University, Shanghai 200072, PR China.
Eur J Med Chem. 2014 Jun 10;80:316-24. doi: 10.1016/j.ejmech.2014.04.070. Epub 2014 Apr 25.
Two ruthenium(II) complexes, Ru(L)2(p-tFMPIP)2 (L = bpy, 1; phen, 2; p-tFMPIP = 2-(4-(trifluoromethyphenyl)-1H-imidazo[4,5f][1,10] phenanthroline)), were prepared by microwave-assisted synthesis technology. The inhibitory activity evaluated by MTT assay shown that 2 can inhibit the growth of MDA-MB-231 cells with inhibitory activity (IC50) of 16.3 μM, which was related to the induction of apoptosis. Besides, 2 exhibit low toxicity against normal HAcat cells. The inhibitory growth activity of both complexes related to the induction of apoptosis was also confirmed. Furthermore, the studies on the interaction of both complexes with c-myc G4 DNA shown that 1 and 2 can stabilize the conformation of c-myc G4 DNA in groove binding mode, which has been rational explained by using DFT theoretical calculation methods. In a word, this type of ruthenium(II) complexes can act as potential apoptosis inducers with low toxicity in clinic by stabilizing c-myc G4 DNA.
两个钌(II)配合物,[Ru(L)2(p-tFMPIP)](ClO4)2(L = bpy,1; phen,2; p-tFMPIP = 2-(4-(三氟甲基)苯基)-1H-咪唑[4,5f][1,10]菲咯啉),通过微波辅助合成技术制备。MTT 测定法评估的抑制活性表明,2 可以抑制 MDA-MB-231 细胞的生长,抑制活性(IC50)为 16.3 μM,这与诱导细胞凋亡有关。此外,2 对正常 HAcat 细胞的毒性较低。两种配合物的生长抑制活性与诱导细胞凋亡有关也得到了证实。此外,对两种配合物与 c-myc G4 DNA 的相互作用研究表明,1 和 2 可以以沟结合模式稳定 c-myc G4 DNA 的构象,这已经通过使用 DFT 理论计算方法得到了合理的解释。总之,这种类型的钌(II)配合物可以通过稳定 c-myc G4 DNA 作为具有低毒性的潜在凋亡诱导剂在临床上发挥作用。